Fetal growth restriction and the development of major depression

Area of Science:

• Perinatal Epidemiology
• Psychiatry
• Developmental Origins of Health and Disease

Background:

• Fetal growth restriction (FGR) is linked to various adverse health outcomes.
• The potential association between FGR and later-life major depressive disorder (MDD) remains unclear.
• Investigating early-life factors for mental health conditions is crucial for public health.

Purpose of the Study:

• To examine the relationship between indicators of fetal growth restriction and the lifetime incidence of major depression.
• To assess if FGR influences the number of recurrent depressive episodes over a lifetime.
• To determine if birth size is a predictor for developing major depression later in life.

Main Methods:

• A cohort of 1101 offspring from the National Collaborative Perinatal Project was analyzed.
• Cox regression models assessed the association between birth size measures (e.g., low birth weight, small for gestational age) and major depression risk.
• Mean depressive episodes were compared across different birth size categories.

Main Results:

• No significant association was found between low birth weight, gestational age, ponderal index, or small for gestational age and the lifetime risk of major depression.
• Fetal growth restriction measures did not correlate with an increased number of recurrent depressive episodes.
• The study found no statistical link between birth size and the development or recurrence of major depression.

Conclusions:

• Fetal growth restriction, indicated by various birth size metrics, is not associated with an increased risk of major depression.
• The findings do not support a 'fetal programming' hypothesis for the development of depression.
• Early life growth appears unrelated to the lifetime risk and recurrence of major depressive disorder.